KIMS Hospitals confirms NIL deviation in warrant fund utilization for Q2 2026

Krishna Institute of Medical Sciences Limited (KIMS Hospitals) has confirmed NIL deviation or variation in the utilization of funds raised through the issue of warrants to its promoter and promoter group. This confirmation pertains to the quarter ended September 30, 2026. The company stated that the utilization of these funds aligns with the objects initially declared in its Postal Ballot Notice dated June 15, 2026.

KIMS Hospitals Reports No Deviation in Warrant Fund Utilization

Krishna Institute of Medical Sciences Limited has officially communicated that there was NIL deviation or variation in the utilization of proceeds from funds raised via the issue of warrants to the Promoter & Promoter group of the company. This statement covers the financial quarter that concluded on September 30, 2026.

Alignment with Stated Objectives

The confirmation, issued under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, aligns with the company’s commitment to transparency. The utilization of the funds raised through these warrants was strictly in accordance with the objects detailed in the Postal Ballot Notice issued on June 15, 2026. The company’s Audit Committee has reviewed this statement and found no discrepancies.

Fund Raising Details

The funds in question were raised through a Public Issue / Rights Issue / Preferential Issue/QIP/Others on August 19, 2026, amounting to Rs. 600 Cr. A portion, Rs. 150 Cr, was received as of the reporting quarter. The stated objects for these funds included repayment or prepayment of certain outstanding borrowings, investment into subsidiaries for similar purposes, and general corporate purposes. The detailed breakdown shows the original allocation was 260.00 Cr for borrowings, 190.00 Cr for subsidiary borrowings, and 150.00 Cr for general corporate purposes. The funds utilized as of the quarter ended September 30, 2026, were Nil for the first two categories and 150.00 Cr for general corporate purposes, with no deviation reported.

Source: BSE

Previous Article

Lohia Corp approves financial results and accepts director resignation

Next Article

Websol Energy confirms no deviation in fund utilisation for Q2 FY27